Cargando…

The Clinical Effectiveness of Intralesional Injection of 2% Zinc Sulfate Solution in the Treatment of Common Warts

Objective. To investigate the clinical efficacy and safety of intralesional injection of 2% zinc sulfate solution in the treatment of common warts. Patients and Methods. One hundred and twenty patients (78 females and 42 males) aged 5–55 years with 225 common warts participated in this prospective m...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Essam-elden Mohamed, Tawfik, Khaled Mohamed, Mahmoud, Asmaa Moneir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830730/
https://www.ncbi.nlm.nih.gov/pubmed/27123361
http://dx.doi.org/10.1155/2016/1082979
_version_ 1782426937898041344
author Mohamed, Essam-elden Mohamed
Tawfik, Khaled Mohamed
Mahmoud, Asmaa Moneir
author_facet Mohamed, Essam-elden Mohamed
Tawfik, Khaled Mohamed
Mahmoud, Asmaa Moneir
author_sort Mohamed, Essam-elden Mohamed
collection PubMed
description Objective. To investigate the clinical efficacy and safety of intralesional injection of 2% zinc sulfate solution in the treatment of common warts. Patients and Methods. One hundred and twenty patients (78 females and 42 males) aged 5–55 years with 225 common warts participated in this prospective monocentric randomized study. All lesions were treated with intralesional injection of 2% zinc sulfate. Results. From 225 warts injected, 135 warts (60%) cured from the first session, 51 warts (22.67%) cured from the second session, and 12 warts (5.33%) cured from the third session. There is no significant relation between improvement and patient's ages, duration, or number of warts (P > 0.05). All patients complained from pain during injection, and all treated lesions showed redness, tenderness, and swelling in the first 3 days after injection. Late complications were postinflammatory hyperpigmentation in 90 patients (75%), scaring in 9 patients (7.5%), and ulceration in 3 patients (2.5%). Recurrence occurred in 3 lesions (1.33%). Conclusion. The clinical data indicate that intralesional injection of 2% zinc sulfate is an effective maneuver in the treatment of common warts; however, its associated complications limit its use.
format Online
Article
Text
id pubmed-4830730
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-48307302016-04-27 The Clinical Effectiveness of Intralesional Injection of 2% Zinc Sulfate Solution in the Treatment of Common Warts Mohamed, Essam-elden Mohamed Tawfik, Khaled Mohamed Mahmoud, Asmaa Moneir Scientifica (Cairo) Clinical Study Objective. To investigate the clinical efficacy and safety of intralesional injection of 2% zinc sulfate solution in the treatment of common warts. Patients and Methods. One hundred and twenty patients (78 females and 42 males) aged 5–55 years with 225 common warts participated in this prospective monocentric randomized study. All lesions were treated with intralesional injection of 2% zinc sulfate. Results. From 225 warts injected, 135 warts (60%) cured from the first session, 51 warts (22.67%) cured from the second session, and 12 warts (5.33%) cured from the third session. There is no significant relation between improvement and patient's ages, duration, or number of warts (P > 0.05). All patients complained from pain during injection, and all treated lesions showed redness, tenderness, and swelling in the first 3 days after injection. Late complications were postinflammatory hyperpigmentation in 90 patients (75%), scaring in 9 patients (7.5%), and ulceration in 3 patients (2.5%). Recurrence occurred in 3 lesions (1.33%). Conclusion. The clinical data indicate that intralesional injection of 2% zinc sulfate is an effective maneuver in the treatment of common warts; however, its associated complications limit its use. Hindawi Publishing Corporation 2016 2016-03-31 /pmc/articles/PMC4830730/ /pubmed/27123361 http://dx.doi.org/10.1155/2016/1082979 Text en Copyright © 2016 Essam-elden Mohamed Mohamed et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Mohamed, Essam-elden Mohamed
Tawfik, Khaled Mohamed
Mahmoud, Asmaa Moneir
The Clinical Effectiveness of Intralesional Injection of 2% Zinc Sulfate Solution in the Treatment of Common Warts
title The Clinical Effectiveness of Intralesional Injection of 2% Zinc Sulfate Solution in the Treatment of Common Warts
title_full The Clinical Effectiveness of Intralesional Injection of 2% Zinc Sulfate Solution in the Treatment of Common Warts
title_fullStr The Clinical Effectiveness of Intralesional Injection of 2% Zinc Sulfate Solution in the Treatment of Common Warts
title_full_unstemmed The Clinical Effectiveness of Intralesional Injection of 2% Zinc Sulfate Solution in the Treatment of Common Warts
title_short The Clinical Effectiveness of Intralesional Injection of 2% Zinc Sulfate Solution in the Treatment of Common Warts
title_sort clinical effectiveness of intralesional injection of 2% zinc sulfate solution in the treatment of common warts
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830730/
https://www.ncbi.nlm.nih.gov/pubmed/27123361
http://dx.doi.org/10.1155/2016/1082979
work_keys_str_mv AT mohamedessameldenmohamed theclinicaleffectivenessofintralesionalinjectionof2zincsulfatesolutioninthetreatmentofcommonwarts
AT tawfikkhaledmohamed theclinicaleffectivenessofintralesionalinjectionof2zincsulfatesolutioninthetreatmentofcommonwarts
AT mahmoudasmaamoneir theclinicaleffectivenessofintralesionalinjectionof2zincsulfatesolutioninthetreatmentofcommonwarts
AT mohamedessameldenmohamed clinicaleffectivenessofintralesionalinjectionof2zincsulfatesolutioninthetreatmentofcommonwarts
AT tawfikkhaledmohamed clinicaleffectivenessofintralesionalinjectionof2zincsulfatesolutioninthetreatmentofcommonwarts
AT mahmoudasmaamoneir clinicaleffectivenessofintralesionalinjectionof2zincsulfatesolutioninthetreatmentofcommonwarts